Article

Essilor gets new certification, partners

Dallas—Essilor of America's North America Operations Supply Chain Organization has received ISO 9001:2000 certification. TUV Rheinland of North America Inc., an independent accredited third-party registrar, conducted the audit.

Dallas-Essilor of America's North America Operations Supply Chain Organization has received ISO 9001:2000 certification. TUV Rheinland of North America Inc., an independent accredited third-party registrar, conducted the audit.

The operating system will enable Essilor to respond to the changing needs of customers, internally and externally. The certification also builds on the ISO 9001:2000 certification of Essilor's Columbus Distribution Center last year, the company said.

"ISO certification for the supply chain organization is a significant additional feather in Essilor's cap," said Steve Freedman, vice president, operations and administration for Essilor Lens Group.

Also, Essilor International recently participated with Safilo Group in the Special Olympics "Opening Eyes" program in France. In 2003, the companies signed a 3-year agreement to support the program, which focuses on helping athletes with intellectual disabilities improve their vision through eye health services and the prescribing and dispensing of eyeglasses. This year, they donated 90 ophthalmic frames, 180 sunglasses, and 180 ophthalmic lenses to participants.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) ASCRS 2025: Mark Lobanoff, MD, on making the move to office-based surgery
Barsha Lal, PhD, discusses the way low dose atropine affects accommodative amplitude and dynamics at the 2025 ARVO meeting
(Image credit: Ophthalmology Times) NeuroOp Guru: When eye findings should prompt neuroimaging in suspected neuro-Behcet disease
At the Association for Research in Vision and Ophthalmology (ARVO) meeting, Katherine Talcott, MD, a retina specialist at Cleveland Clinic, shared her findings on EYP-1901 (EyePoint Pharmaceuticals) in the phase 2 DAVIO study.
Dr. Jogin Desai, founder of Eyestem Research, discusses his research at the Association for Research in Vision and Ophthalmology.
(Image credit: Ophthalmology Times) ASCRS 2025: Michael Rivers, MD, shares his takeaways as a panelist at the inaugural SightLine event
(Image credit: Ophthalmology Times) ASCRS 2025: Karl Stonecipher, MD, on LASIK outcomes using an aspheric excimer laser for high myopia
John Tan talks about an emergency triage framework for retinal artery occlusion at the 2025 Association for Research in Vision and Ophthalmology (ARVO) meeting.
Dr Robert Maloney at the 2025 Controversies in Modern Eye Care meeting
Wendy Lee, MD, MS, at Controversies in Modern Eye Care 2025.
© 2025 MJH Life Sciences

All rights reserved.